Characterisation of renal immune cell infiltrates in children with nephrotic syndrome

Pediatric Nephrology

Volumn 25, Issue 7, 2010, Pages 1291-1298

  Benz, Kerstin ^a,b   Büttner, Maike ^b   Dittrich, Katalin ^a   Campean, Valentina ^b   Dötsch, Jörg ^a   Amann, Kerstin ^b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

B lymphocyte; Idiopathic nephrotic syndrome; Macrophage; Renal infiltration; T lymphocyte

Indexed keywords

CD20 ANTIBODY; CD21 ANTIBODY; CD3 ANTIBODY; CD3 ANTIGEN; CD4 ANTIBODY; CD4 ANTIGEN; CD68 ANTIBODY; CD68 ANTIGEN; CD8 ANTIBODY; CD8 ANTIGEN; CELL ANTIBODY; COMPLEMENT COMPONENT C3D RECEPTOR; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; STEROID; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR FOXP3 ANTIBODY; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLICULAR DENDRITIC CELL; HUMAN; HUMAN TISSUE; IMMUNOADSORPTION; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY BIOPSY; KIDNEY CELL; KIDNEY TUBULE BASEMENT MEMBRANE; KIDNEY TUBULE DISORDER; LYMPHOCYTE COUNT; MACROPHAGE; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; T LYMPHOCYTE;

ADOLESCENT; ANTIGENS, CD; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; DENDRITIC CELLS, FOLLICULAR; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY; KIDNEY GLOMERULUS; LEUKOCYTES; MACROPHAGES; MALE; MONONUCLEAR PHAGOCYTE SYSTEM; NEPHROSIS, LIPOID; NEPHROTIC SYNDROME; RETROSPECTIVE STUDIES; T-LYMPHOCYTES;

EID: 77954540690     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-010-1507-0     Document Type: Article

References (31)

1. Shalhoub RJ (1974) Pathogenesis of lipoid nephrosis. A disorder of T-cell function. Lancet 2:556-560
2. Lin CY, Lee BH, Lin CC, Chen WP (1990) A study of the relationship between childhood nephrotic syndrome and allergic diseases. Chest 97:1408-1411
3. Groshong T, Mendelson L, Mendoza S, Bazaral M, Hamburger R, Tune B (1973) Serum IgE in patients with minimal change nephrotic syndrome. J Pediatr 83:767-771
4. Van Den Berg JG, Weening JJ (2004) Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome. Clin Sci (Lond) 107:125-136
5. Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M (1991) A glomerular permeability factor produced by human Tcell hybridomas. Kidney Int 40:453-460
6. Lama G, Luongo I, Tirino G, Borriello A, Carangio C, Salsano ME (2002) T-lymphocyte populations and cytokines in childhood nephrotic syndrome. Am J Kidney Dis 39:958-965
7. Dötsch J, Müller-Wiefel DE, Kemper MJ (2008) Rituximab: is replacement of cyclophosphamide and calcineurin inhibitors in steroid-dependent nephrotic syndrome possible? Pediatr Nephrol 23:3-7
8. Wada T, Pippin JW, Marshall CB, Griffin SV, Shankland SJ (2005) Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and bcl-2-related family proteins. J Am Soc Nephrol 16:2615-2625
9. Mathieson PW (2008) Proteinuria and immunity-an overstated relationship? N Engl J Med 359:2492-2494
10. Benz K, Dötsch J, Rascher W, Stachel D (2004) Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy. Pediatr Nephrol 19:794-797
11. Gilbert RD, Hulse E, Rigden S (2006) Rituximab therapy for steroid-dependent minimal change nephrotic syndrome. Pediatr Nephrol 21:1698-1700
12. Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Tague S, Ronco P, Bouissou F (2008) Rituximab treatment for severe steroid-or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol 23:1269-1279
13. Arbeitsgemeinschaft für Pädiatrische Nephrologie (APN) (1981) Alternate-day prednisone is more effective than intermittent prednisone in frequently relapsing nephrotic syndrome. Eur J Pediatr 135:229-237
14. Frank K, Zeier M, Gross ML, Waldherr R, Ritz E, Amann K (2006) Comprehensive immunohistological analysis of the endothelin system in human kidney grafts. Nephrol Dial Transplant 21:1365-1372
15. Kemper MJ, Zepf K, Klaassen I, Link A, Müller-Wiefel DE (2005) Changes of lymphocyte populations in pediatric steroidsensitive nephrotic syndrome are more pronounced in remission than in relapse. Am J Nephrol 25:132-137
16. Sahali D, Pawlak A, Le Gouvello S, Lang P, Valanciute A, Remy P, Loirat C, Niaudet P, Benson A, Guellaen G (2001) Transcriptional and post-transcriptional alterations of NFkB-alpha in active minimal change nephrotic syndrome. J Am Soc Nephrol 12:1648-1658
17. Kimata H, Fujimoto M, Furusho K (1995) Involvement of interleukin (IL)-13, but not IL-4 in spontaneous IgE and IgG4 production in nephrotic syndrome. Eur J Immunol 25:1497-1501
18. Shao XS, Yang XQ, Zhao XD, Li Q, Xie YY, Wang XG, Wang M, Zhang W (2009) The prevalence of Th17 cells and FOXP3 regulate T-cells (Treg) in children with primary nephrotic syndrome. Pediatr Nephrol 24:1683-1690
19. Frank C, Herrmann M, Fernandez S, Dirnecker D, Böswald M, Kolowos W, Ruder H, Haas JP (2000) Dominant T-cells in idiopathic nephrotic syndrome of childhood. Kidney Int 57:510-517
20. Andre S, Tough DF, Lacroix-Desmazes S, Kaveri SV, Bayry J (2009) Surveillance of antigen-presenting cells by CD4+ CD35+ regulatory T-cells in autoimmunity: immunopathogenesis and therapeutic implications. Am J Pathol 174:1575-1587
21. Mahajan D, Wang Y, Qin X, Wang Y, Zheng G, Wang YM, Alexander SI, Harris DC (2006) CD4+CD25+ regulatory T-cells protect against injury in an innate murine model of chronic kidney disease. J Am Soc Nephrol 17:2731-2741
22. Le Berre L, Bruneau S, Naulet J, Renaudin K, Buzelin F, Usal C, Snit H, Condamine T, Soulilou JP, Dantal J (2009) Induction of T regulatory cells attenuates idiopathic nephrotic syndrome. J Am Soc Nephrol 20:57-67
23. Bagga A, Sinha A, Moudgil A (2007) Rituximab in patients with the steroid-resistant nephrotic syndrome. N Engl J Med 356:2751-2752
24. Kemper MJ, Meyer-Jark T, Lilova M, Müller-Wiefel DE (2003) Combined T- and B-cell activation in childhood steroid sensitive nephrotic syndrome. Clin Nephrol 60:242-247
25. Yabu JM, Ho B, Scandling JD, Vincenti F (2008) Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis. Am J Transplant 8:222-227
26. Remuzzi G, Chiurchiu C, Abbate M, Brusegan V, Bontempelli M, Ruggenenti P (2002) Rituximab for idiopathic membranous nephropathy. Lancet 360:923-924
27. Fervenza FC, Cosio FG, Erickson SB, Specks U, Herzenberg AM, Dillon JJ, Leung N, Cohen IM, Wochos DN, Bergstralh E, Hladunewich M, Cattran DC (2008) Rituximab treatment of idiopathic membranous nephropathy. Kidney Int 73:117-125 (Pubitemid 350273646)
28. Cohen CD, Calvaresi N, Armelloni S, Schmid H, Henger A, Ott U, Rastaldi MP, Kretzler M (2005) CD 20 positive infiltrates in human membranous glomerulonephritis. J Nephrol 18:328-333
29. Sarwal M, Chua MS, Kambham N, Hsieh SC, Satterwhite T, Masek M, Salvatierra O Jr (2003) Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 349:125-138 (Pubitemid 36818782)
30. Scheepstra C, Bemelman FJ, Van Der Loos C, Rowshani AT, Van Donselaar-Van Der Pant KA, Idu MM, Ten Berge IJ, Florquin S (2008) B-cells in cluster or in a scattered pattern do not correlate with clinical outcome of renal allograft rejection. Transplantation 27:772-778
31. Hotta O, Yusa N, Kitamura H, Taguma Y (2000) Urinary macrophages as activity markers of renal injury. Clin Chim Acta 297:123-133